Thrombocytopenia and Coronary Artery Disease, the Existing Dilemmas
Background: Platelets play a pivotal role in the pathogenesis of acute coronary syndrome (ACS) and acute or chronic complications following percutaneous coronary intervention (PCI) as well. Platelet inhibition is a cornerstone treatment in the management of these patients. Thrombocytopenia in patien...
Main Authors: | Davarashvili Ilia, Hasin Tal, Asher Elad |
---|---|
Format: | Article |
Language: | English |
Published: |
Sciendo
2019-09-01
|
Series: | Journal of Cardiovascular Emergencies |
Subjects: | |
Online Access: | https://doi.org/10.2478/jce-2019-0011 |
Similar Items
-
Management of patients with immune thrombocytopenia in the Moscow region
by: S. G. Zakharov, et al.
Published: (2022-11-01) -
Gaucher disease carrier with gestational thrombocytopenia and anemia: a case report
by: Takako Sugiura, et al.
Published: (2022-05-01) -
The role of hydroxychloroquine as a steroid-sparing agent in the treatment of immune thrombocytopenia: A review of the literature
by: Fatemeh Mohammadpour, et al.
Published: (2018-01-01) -
CAUSES OF DEVELOPMENT OF ACUTE AND CHRONIC THROMBOCYTOPENIA IN CHILDREN OF IRKUTSK REGION
by: N. N. Martynovich, et al.
Published: (2018-09-01) -
Refractory Severe Thrombocytopenia during Pregnancy: How to Manage
by: Joana Gomes de Amorim, et al.
Published: (2018-12-01)